Tricyclic compounds useful as inhibitors of kinases

Details for Australian Patent Application No. 2006316322 (hide)

Owner Merck Canada Ltd. Merck Sharp & Dohme Corp.

Inventors Mellon, Christophe; Lau, Cheuk; Young, Jonathan R.; Otte, Ryan D.; Leblanc, Yves; Truchon, Jean-Francois; Isabel, Elise; Lachance, Nicolas; Roy, Patrick

Agent Spruson & Ferguson

Pub. Number AU-B-2006316322

PCT Pub. Number WO2007/061764

Priority 60/738,905 22.11.05 US

Filing date 17 November 2006

Wipo publication date 31 May 2007

Acceptance publication date 25 August 2011

International Classifications

C07D 487/02 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

Event Publications

29 May 2008 PCT application entered the National Phase

  PCT publication WO2007/061764 Priority application(s): WO2007/061764

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Frosst Canada Ltd.; Merck Sharp & Dohme Corp. Amendments

25 August 2011 Application Accepted

  Published as AU-B-2006316322

22 December 2011 Standard Patent Sealed

4 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Canada Inc.; Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006316334-Optical article having anti-theft feature and a system and method for inhibiting theft of same

2006316321-Indole orexin receptor antagonists